These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 25168665)

  • 1. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
    Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
    Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
    Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
    Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
    Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S
    Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
    Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
    Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
    Irving G; Tanenberg RJ; Raskin J; Risser RC; Malcolm S
    Int J Clin Pract; 2014 Sep; 68(9):1130-40. PubMed ID: 24837444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
    Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
    Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
    Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
    Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.
    Vinik A; Emir B; Parsons B; Cheung R
    Pain Med; 2014 Apr; 15(4):661-70. PubMed ID: 24330406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
    Carlos F; Espejel L; Novick D; López R; Flores D
    Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
    Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
    Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
    Jha S; Sahani OP; Siddiqui S; Verma MK; Mazumder A; Waghdhare S
    J Assoc Physicians India; 2019 Nov; 67(11):32-36. PubMed ID: 31793266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
    Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
    Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
    Roy MK; Kuriakose AS; Varma SK; Jacob LA; Beegum NJ
    Diabetes Metab Syndr; 2017; 11(1):31-35. PubMed ID: 27484440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic Neuralgia.
    Parsons B; Emir B; Knapp L
    Am J Ther; 2015; 22(4):257-68. PubMed ID: 25272094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
    Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
    Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
    J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral Neuropathy.
    Alexander J; Edwards RA; Brodsky M; Savoldelli A; Manca L; Grugni R; Emir B; Whalen E; Watt S; Parsons B
    Clin Drug Investig; 2019 Aug; 39(8):775-786. PubMed ID: 31243706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.